Figure 7: Functional Impact of GLC Receptor Antagonist on Contractile Function Measured by Echocardiogram

(A) Ejection fraction and (B) fractional shortening were measured at basal (week 0), 2 weeks post-TAC (week 2) and 5 weeks post-TAC from each treatment group as indicated. *p < 0.05 TAC versus TAC + REMD; #p < 0.05 TAC versus TAC + REMD therapy. Abbreviations as in Figures 1 and 5.